Danske Bank’s DNA X Inc SONM Stock Holding History

Danske Bank’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$16	–	1216
2026 Q1	$16	Hold	4	–	–	﹤0.01%	1077
2025 Q4	$13	Buy	+4	New	+$36	﹤0.01%	1477
2025 Q3	–	Hold	0	–	–	–	1486
2025 Q2	–	Hold	0	–	–	–	1519
2025 Q1	–	Hold	0	–	–	–	1348
2024 Q4	–	Hold	0	–	–	–	1371
2024 Q3	–	Hold	0	–	–	–	1568

Other funds holding SONM

CWM

C2C Wealth Management Scottsdale, Arizona $128M AUM 22.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Danske Bank's SONM Position: Q2 2026 in Review

Danske Bank sold out of DNA X Inc (SONM) in Q2 2026, closing a stake of 4 shares — an estimated $16 sold.

Danske Bank first reported a position in SONM in Q4 2025 and held it in 2 quarters. The position peaked at $16 in Q1 2026. 9 funds tracked by Wall St. Rank hold SONM as of Q2 2026.

Danske Bank reported no remaining DNA X Inc position as of Q2 2026 after selling out during the quarter.
Danske Bank sold 4 DNA X Inc shares in Q2 2026, an estimated $16.
Danske Bank first reported a position in DNA X Inc in Q4 2025 and held it in 2 quarters.
Danske Bank's DNA X Inc position peaked at $16 in Q1 2026.
9 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.